Page 4 of 8
Where was this study done?
Study sites were in four countries.
Number of patients who received at least one dose of
study medicine
Canada 4
Netherlands 4
United Kingdom 14
United States 13
0 5 10 15
Number of patients
What were the main results of the study?
Safety was measured by recording adverse events and monitoring patientsâ€™ test results.
Adverse events
The figure below shows the number of patients who had adverse events, including
serious adverse events, from Day 1 onwards.
Number of patients with adverse events from Day 1 onwards